Global Irritable Bowel Syndrome (IBS) Market – Tremendous Growth, Key Factors, Top Companies, Major Drivers, Region and Forecast (2020-2025)

(The Express Wire via Comtex)

"Global Irritable Bowel Syndrome (IBS) Market Report" provides, wherever applicable and relevant, technical data of products, and sheds useful light on expected commercial production dates and current R&D status. This report will help the viewer in Better Decision Making.

According to this study, over the next five years the Irritable Bowel Syndrome (IBS) market will register a 16.6% CAGR in terms of revenue, the global market size will reach US$ 5531.4 million by 2024, from US$ 2992.8 million in 2019. In particular, this report presents the global revenue market share of key companies in Irritable Bowel Syndrome (IBS) business, shared in Chapter 3.

Access the PDF sample of the report @ https://www.orbisresearch.com/contacts/request-sample/4099304


This report presents a comprehensive overview, market shares and growth opportunities of Irritable Bowel Syndrome (IBS) market by product type, application, key companies and key regions.

This study considers the Irritable Bowel Syndrome (IBS) value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
IBS-D Drug
IBS-C Drug
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Women
Men


This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East and Africa
Egypt
South Africa
Israel
Turkey
GCC Countries


The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan
Bausch Health
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Takeda
IM HealthScience
Sebela Pharmaceuticals
Astellas Pharmaceuticals


In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.


Research objectives
To study and analyze the global Irritable Bowel Syndrome (IBS) market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Irritable Bowel Syndrome (IBS) market by identifying its various subsegments.
Focuses on the key global Irritable Bowel Syndrome (IBS) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Irritable Bowel Syndrome (IBS) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Irritable Bowel Syndrome (IBS) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.


To strategically profile the key players and comprehensively analyze their growth strategies.
Browse the full report @ https://www.orbisresearch.com/reports/index/global-irritable-bowel-syndrome-ibs-market-growth-status-and-outlook-2019-2024


Table of Contents
Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2019-2024
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered


2 Executive Summary
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Market Size 2014-2024
2.1.2 Irritable Bowel Syndrome (IBS) Market Size CAGR by Region
2.2 Irritable Bowel Syndrome (IBS) Segment by Type
2.2.1 IBS-D Drug
2.2.2 IBS-D Drug
2.2.3 Other
2.3 Irritable Bowel Syndrome (IBS) Market Size by Type
2.3.1 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2014-2019)
2.3.2 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type (2014-2019)
2.4 Irritable Bowel Syndrome (IBS) Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Irritable Bowel Syndrome (IBS) Market Size by Application
2.5.1 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2014-2019)
2.5.2 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Application (2014-2019)


3 Global Irritable Bowel Syndrome (IBS) by Players
3.1 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Players
3.1.1 Global Irritable Bowel Syndrome (IBS) Market Size by Players (2017-2019)
3.1.2 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Players (2017-2019)
3.2 Global Irritable Bowel Syndrome (IBS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers and Acquisitions, Expansion


4 Irritable Bowel Syndrome (IBS) by Regions
4.1 Irritable Bowel Syndrome (IBS) Market Size by Regions
4.2 Americas Irritable Bowel Syndrome (IBS) Market Size Growth
4.3 APAC Irritable Bowel Syndrome (IBS) Market Size Growth
4.4 Europe Irritable Bowel Syndrome (IBS) Market Size Growth
4.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Growth


5 Americas
5.1 Americas Irritable Bowel Syndrome (IBS) Market Size by Countries
5.2 Americas Irritable Bowel Syndrome (IBS) Market Size by Type
5.3 Americas Irritable Bowel Syndrome (IBS) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries


6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Market Size by Countries
6.2 APAC Irritable Bowel Syndrome (IBS) Market Size by Type
6.3 APAC Irritable Bowel Syndrome (IBS) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries


7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) by Countries
7.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries


8 Middle East and Africa
8.1 Middle East and Africa Irritable Bowel Syndrome (IBS) by Countries
8.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size by Type
8.3 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends


10 Global Irritable Bowel Syndrome (IBS) Market Forecast
10.1 Global Irritable Bowel Syndrome (IBS) Market Size Forecast (2019-2024)
10.2 Global Irritable Bowel Syndrome (IBS) Forecast by Regions
10.2.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East and Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East and Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Irritable Bowel Syndrome (IBS) Forecast by Type
10.8 Global Irritable Bowel Syndrome (IBS) Forecast by Application


11 Key Players Analysis
11.1 Allergan
11.1.1 Company Details
11.1.2 Irritable Bowel Syndrome (IBS) Product Offered
11.1.3 Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Allergan News
11.2 Bausch Health
11.2.1 Company Details
11.2.2 Irritable Bowel Syndrome (IBS) Product Offered
11.2.3 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Bausch Health News
11.3 Sucampo Pharmaceuticals
11.3.1 Company Details
11.3.2 Irritable Bowel Syndrome (IBS) Product Offered
11.3.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Sucampo Pharmaceuticals News
11.4 McNeil Consumer Healthcare
11.4.1 Company Details
11.4.2 Irritable Bowel Syndrome (IBS) Product Offered
11.4.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 McNeil Consumer Healthcare News
11.5 Takeda
11.5.1 Company Details
11.5.2 Irritable Bowel Syndrome (IBS) Product Offered
11.5.3 Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Takeda News
11.6 IM HealthScience
11.6.1 Company Details
11.6.2 Irritable Bowel Syndrome (IBS) Product Offered
11.6.3 IM HealthScience Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 IM HealthScience News
11.7 Sebela Pharmaceuticals
11.7.1 Company Details
11.7.2 Irritable Bowel Syndrome (IBS) Product Offered
11.7.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Sebela Pharmaceuticals News
11.8 Astellas Pharmaceuticals
11.8.1 Company Details
11.8.2 Irritable Bowel Syndrome (IBS) Product Offered
11.8.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Astellas Pharmaceuticals News


12 Research Findings and Conclusion


Direct purchase the report @ https://www.orbisresearch.com/contact/purchase-single-user/4099304


About Us:


Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.


Contact Us:


Hector Costello
Senior Manager Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (972)-362-8199; +91 895 659 5155

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Global Irritable Bowel Syndrome (IBS) Market - Tremendous Growth, Key Factors, Top Companies, Major Drivers, Region and Forecast (2020-2025)